Bryan Hunt
Chief Financial Officer
CFO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Health Catalyst, Inc. (HCAT) | Former Chief Financial Officer The reported amounts represent the aggregate grant date fair value of awards of RSUs and PRSUs granted in each year presented, computed in accordance with FASB ASC Topic 718, excluding the estimate of forfeitures not related to the performance-based vesting of PRSUs. Amounts reflect the fair value of each award based on the closing price of our common stock on the Nasdaq Global Select Market on the date of grant of the award. The grant date fair value of the PRSUs is based on the probable outcome of the vesting conditions as of the grant date. For fiscal 2024, the grant date fair value of all long-term PRSUs at maximum performance achievement, are $2,427,500, $282,100, $534,050, and $364,125 for Messrs. Burton, Alger, Freeman, and Landry, respectively, and $315,575, for Ms. Llewelyn. Represents the cash amounts earned by our named executive officers under our short-term incentive plan (the Bonus Plan), based on our achievement of certain corporate performance goals. For a description of the Bonus Plan, see the section titled “Compensation Discussion and Analysis - Annual Performance-Based Incentives” above. For fiscal 2024, the amounts reported represent matching contributions made by us under our 401(k) plan ($13,800 for Messrs. Burton, Alger, Freeman, Landry, and Ms. Llewlyn respectively, and $3,350 for Mr. Hunt), executive life insurance premiums paid by us ($578 for Mr. Burton and $926 for Ms. Llewelyn), executive long-term disability insurance premiums paid by us ($2,057 for Mr. Burton, and $1,983 Ms. Llewelyn), gift cards paid by us as part of a benefit provided to all team members ($19 for Mr. Landry), and severance paid by us ($247,500 for Mr. Hunt). Mr. Burton voluntarily reduced his cash and new equity compensation by 100% from July 2022 through December 2023 in response to the challenging macroeconomic environment and to lead by example as part of our cost reduction initiatives. As part of his compensation reduction, he also declined receiving the cash portion of his annual bonus for fiscal 2022 and 2023. Effective January 1, 2025, his base salary increased to $525,000. | $83,750 | $798,455 |
| 2023 | Health Catalyst, Inc. (HCAT) | Former Chief Financial Officer The reported amounts represent the aggregate grant date fair value of awards of RSUs and PRSUs granted in each year presented, computed in accordance with FASB ASC Topic 718, excluding the estimate of forfeitures not related to the performance-based vesting of PRSUs. Amounts reflect the fair value of each award based on the closing price of our common stock on the Nasdaq Global Select Market on the date of grant of the award. The grant date fair value of the PRSUs is based on the probable outcome of the vesting conditions as of the grant date. For fiscal 2024, the grant date fair value of all long-term PRSUs at maximum performance achievement, are $2,427,500, $282,100, $534,050, and $364,125 for Messrs. Burton, Alger, Freeman, and Landry, respectively, and $315,575, for Ms. Llewelyn. Represents the cash amounts earned by our named executive officers under our short-term incentive plan (the Bonus Plan), based on our achievement of certain corporate performance goals. For a description of the Bonus Plan, see the section titled “Compensation Discussion and Analysis - Annual Performance-Based Incentives” above. For fiscal 2024, the amounts reported represent matching contributions made by us under our 401(k) plan ($13,800 for Messrs. Burton, Alger, Freeman, Landry, and Ms. Llewlyn respectively, and $3,350 for Mr. Hunt), executive life insurance premiums paid by us ($578 for Mr. Burton and $926 for Ms. Llewelyn), executive long-term disability insurance premiums paid by us ($2,057 for Mr. Burton, and $1,983 Ms. Llewelyn), gift cards paid by us as part of a benefit provided to all team members ($19 for Mr. Landry), and severance paid by us ($247,500 for Mr. Hunt). Mr. Burton voluntarily reduced his cash and new equity compensation by 100% from July 2022 through December 2023 in response to the challenging macroeconomic environment and to lead by example as part of our cost reduction initiatives. As part of his compensation reduction, he also declined receiving the cash portion of his annual bonus for fiscal 2022 and 2023. Effective January 1, 2025, his base salary increased to $525,000. | $315,000 | $2,385,310 |
| 2022 | Health Catalyst, Inc. (HCAT) | Former Chief Financial Officer The reported amounts represent the aggregate grant date fair value of awards of RSUs and PRSUs granted in each year presented, computed in accordance with FASB ASC Topic 718, excluding the estimate of forfeitures not related to the performance-based vesting of PRSUs. Amounts reflect the fair value of each award based on the closing price of our common stock on the Nasdaq Global Select Market on the date of grant of the award. The grant date fair value of the PRSUs is based on the probable outcome of the vesting conditions as of the grant date. For fiscal 2024, the grant date fair value of all long-term PRSUs at maximum performance achievement, are $2,427,500, $282,100, $534,050, and $364,125 for Messrs. Burton, Alger, Freeman, and Landry, respectively, and $315,575, for Ms. Llewelyn. Represents the cash amounts earned by our named executive officers under our short-term incentive plan (the Bonus Plan), based on our achievement of certain corporate performance goals. For a description of the Bonus Plan, see the section titled “Compensation Discussion and Analysis - Annual Performance-Based Incentives” above. For fiscal 2024, the amounts reported represent matching contributions made by us under our 401(k) plan ($13,800 for Messrs. Burton, Alger, Freeman, Landry, and Ms. Llewlyn respectively, and $3,350 for Mr. Hunt), executive life insurance premiums paid by us ($578 for Mr. Burton and $926 for Ms. Llewelyn), executive long-term disability insurance premiums paid by us ($2,057 for Mr. Burton, and $1,983 Ms. Llewelyn), gift cards paid by us as part of a benefit provided to all team members ($19 for Mr. Landry), and severance paid by us ($247,500 for Mr. Hunt). Mr. Burton voluntarily reduced his cash and new equity compensation by 100% from July 2022 through December 2023 in response to the challenging macroeconomic environment and to lead by example as part of our cost reduction initiatives. As part of his compensation reduction, he also declined receiving the cash portion of his annual bonus for fiscal 2022 and 2023. Effective January 1, 2025, his base salary increased to $525,000. | $300,000 | $3,187,457 |
| 2021 | Health Catalyst, Inc. (HCAT) | Chief Financial Officer | $274,061 | $3,462,730 |
Executive changes
Earnings-call appearances
-
Health Catalyst, Inc. Q4 FY2023 Earnings Call2024-02-22
Health Catalyst, Inc. (HCAT)
-
Health Catalyst, Inc. Q3 FY2023 Earnings Call2023-10-27
Health Catalyst, Inc. (HCAT)
-
Health Catalyst, Inc. Q2 FY2023 Earnings Call2023-08-08
Health Catalyst, Inc. (HCAT)
-
Health Catalyst, Inc. Q1 FY2023 Earnings Call2023-05-09
Health Catalyst, Inc. (HCAT)
-
Health Catalyst, Inc. Q4 FY2022 Earnings Call2023-02-28
Health Catalyst, Inc. (HCAT)
-
Health Catalyst, Inc. Q3 FY2022 Earnings Call2022-11-08
Health Catalyst, Inc. (HCAT)
-
Health Catalyst, Inc. Q2 FY2022 Earnings Call2022-08-04
Health Catalyst, Inc. (HCAT)
-
Health Catalyst, Inc. Q1 FY2022 Earnings Call2022-05-10
Health Catalyst, Inc. (HCAT)
-
Health Catalyst, Inc. Q4 FY2021 Earnings Call2022-03-01
Health Catalyst, Inc. (HCAT)
-
Health Catalyst, Inc. Q3 FY2021 Earnings Call2021-11-09
Health Catalyst, Inc. (HCAT)
-
Health Catalyst, Inc. Q2 FY2021 Earnings Call2021-08-05
Health Catalyst, Inc. (HCAT)
-
Health Catalyst, Inc. Q1 FY2021 Earnings Call2021-05-06
Health Catalyst, Inc. (HCAT)
-
Health Catalyst, Inc. Q4 FY2020 Earnings Call2021-02-25
Health Catalyst, Inc. (HCAT)
-
Performance Food Group Co Q4 FY2020 Earnings Call2020-08-12
Performance Food Group Co (PFGC)
-
Albertsons Companies, Inc. Q3 FY2020 Earnings Call2020-01-07
Albertsons Companies, Inc. (ACI)
-
Lamb Weston Holdings, Inc. Q2 FY2020 Earnings Call2020-01-03
Lamb Weston Holdings, Inc. (LW)
-
GameStop Corp. Q2 FY2020 Earnings Call2019-08-31
GameStop Corp. (GME)
-
B&G Foods, Inc. Q2 FY2020 Earnings Call2019-07-31
B&G Foods, Inc. (BGS)
-
B&G Foods, Inc. Q1 FY2020 Earnings Call2019-04-30
B&G Foods, Inc. (BGS)